In the subset of patients with T1G3 bladder cancer, EGFR status was 80% sensitive and 93% specific in predicting stage progression.[49] Cell cycle regulators, by regulating the transition from the G1 to S phase in the cell cycle, also have prognostic significance in T1G3 disease. This evidence concerns the gene EGFR and urinary bladder carcinoma.